These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 18677154)

  • 21. Hormone replacement therapy in women with breast cancer.
    Braendle W
    Anticancer Res; 1998; 18(3C):2253-5. PubMed ID: 9703796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risks, benefits, and effects on quality of life of selective estrogen-receptor modulator therapy in postmenopausal women at increased risk of breast cancer.
    Ganz PA; Land SR
    Menopause; 2008; 15(4 Suppl):797-803. PubMed ID: 18596601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of hormone treatment on hemostasis variables.
    Kluft C
    Climacteric; 2007 Oct; 10 Suppl 2():32-7. PubMed ID: 17882670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hormone therapy and risk for venous thromboembolism in postmenopausal women].
    Lacut K; Oger E
    Rev Prat; 2005 Feb; 55(4):389-92. PubMed ID: 15828617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hormonal aspects of endometrial cancer.
    Sutton G
    Curr Opin Obstet Gynecol; 1990 Feb; 2(1):69-73. PubMed ID: 2102309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hormone therapy and raloxifene reduce the coagulation inhibitor potential.
    Andresen MS; Eilertsen AL; Abildgaard U; Sandset PM
    Blood Coagul Fibrinolysis; 2007 Jul; 18(5):455-60. PubMed ID: 17581320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Relation between hormonal therapy and tibolone with SERMs in postmenopausal women's myomes growth].
    Carranza Lira S
    Ginecol Obstet Mex; 2008 Oct; 76(10):610-4. PubMed ID: 19062511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What happened to WHI: menopausal hormonal therapy in 2012.
    Hansen KA; Eyster KM
    Clin Obstet Gynecol; 2012 Sep; 55(3):706-12. PubMed ID: 22828102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hormone replacement therapy and gynecological cancer.
    Gadducci A; Fanucchi A; Cosio S; Genazzani AR
    Anticancer Res; 1997; 17(5B):3793-8. PubMed ID: 9427782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pros and cons of existing treatment modalities in osteoporosis: a comparison between tibolone, SERMs and estrogen (+/-progestogen) treatments.
    Kloosterboer HJ; Ederveen AG
    J Steroid Biochem Mol Biol; 2002 Dec; 83(1-5):157-65. PubMed ID: 12650712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progestogens in postmenopausal hormone therapy and the risk of breast cancer.
    Lambrinoudaki I
    Maturitas; 2014 Apr; 77(4):311-7. PubMed ID: 24485796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postmenopausal hormone therapy and breast cancer.
    Prescrire Int; 2009 Apr; 18(100):66-7. PubMed ID: 19585723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An evidence-based approach to hormonal therapies for premenopausal women with fibroids.
    Lethaby AE; Vollenhoven BJ
    Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):307-31. PubMed ID: 17905660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An analysis of ovarian cancer in the Million Women Study.
    Neves-E-Castro M
    Gynecol Endocrinol; 2007 Jul; 23(7):410-3. PubMed ID: 17701773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term effects of the levonorgestrel-releasing intrauterine system on serum lipids and the endometrium in breast cancer patients taking tamoxifen.
    Kesim MD; Aydin Y; Atis A; Mandiraci G
    Climacteric; 2008 Jun; 11(3):252-7. PubMed ID: 18568790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Estrogen-progestin contraception. Disadvantages of estrogen reduction].
    Denis C
    Contracept Fertil Sex; 1993 Jun; 21(6):481-8. PubMed ID: 7920935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system.
    Eilertsen AL; Liestøl S; Mowinckel MC; Hemker HC; Sandset PM
    Thromb Haemost; 2007 Jun; 97(6):938-43. PubMed ID: 17549295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hormone therapy and thromboembolic disease.
    Battaglioli T; Martinelli I
    Curr Opin Hematol; 2007 Sep; 14(5):488-93. PubMed ID: 17934355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogen and progestogen therapy in postmenopausal women.
    Practice Committee of American Society for Reproductive Medicine
    Fertil Steril; 2008 Nov; 90(5 Suppl):S88-102. PubMed ID: 19007655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hormone replacement therapy and endometrial, ovarian and colorectal cancer.
    Gambacciani M; Monteleone P; Sacco A; Genazzani AR
    Best Pract Res Clin Endocrinol Metab; 2003 Mar; 17(1):139-47. PubMed ID: 12763517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.